Page last updated: 2024-12-08
triple dye
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Triple Dye: consists of brilliant green, proflavine hemisulfate, & crystal violet [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 193790 |
MeSH ID | M0062602 |
Synonyms (4)
Synonym |
---|
39389-84-9 |
triple dye |
n-(4-((4-(diethylamino)phenyl)phenylmethylene)-2,5-cyclohexadien-1-ylidene)-n-ethylethanaminium, sulfate (1:1), mixt. with 3,6-acridinediamine sul(1:1) & n-(4-(bis(4-dimethylamino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-methyl methanaminium chlor |
acridine-3,6-diamine;[4-[bis[4-(dimethylamino)phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium;[4-[[4-(diethylamino)phenyl]-phenylmethylidene]cyclohexa-2,5-dien-1-ylidene]-diethylazanium;sulfuric acid;chloride;sulfate |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 45.88
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (45.88) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 4 (33.33%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 2 (16.67%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (50.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |